Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 245 participants.

Also called NCT01514162

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 245 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01514162
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01514162. Allocation not applicable; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2014-10 (actual). Results posted on 2017-05-31.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve
Condition
Heart Valve Diseases
Intervention (Device)
Trifecta valve
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01514162
Content hash
89529f6d587e4749fa900b333a0f1920e4e5e32876e03c62ce3ec792ea2ac20b